Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study

• Ben Parker,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Health Economics and Outcomes Research Ltd, Pontprennau, Cardiff, United Kingdom

  ⨯
• Tom Ward,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Health Economics and Outcomes Research Ltd, Pontprennau, Cardiff, United Kingdom

  ⨯
• Olivia Hayward,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Health Economics and Outcomes Research Ltd, Pontprennau, Cardiff, United Kingdom

  https://orcid.org/0000-0002-9944-5450

  ⨯
• Ian Jacob ,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: ian.jacob@heor.co.uk (IJ); nicolas.x.van-de-velde@gsk.com (NVdV)

  Affiliation Health Economics and Outcomes Research Ltd, Pontprennau, Cardiff, United Kingdom

  ⨯
• Erin Arthurs,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Health Economics & Outcomes Research, GlaxoSmithKline, Toronto, Ontario, Canada

  ⨯
• Debbie Becker,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Quadrant Health Economics Inc, Cambridge, Ontario, Canada

  ⨯
• Sarah-Jane Anderson,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Value Evidence and Outcomes, GlaxoSmithKline, Brentford, Middlesex, United Kingdom

  ⨯
• Vasiliki Chounta,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Global Health Outcomes, ViiV Healthcare Ltd, Brentford, Middlesex, United Kingdom

  ⨯
• Nicolas Van de Velde

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: ian.jacob@heor.co.uk (IJ); nicolas.x.van-de-velde@gsk.com (NVdV)

  Affiliation Global Health Outcomes, ViiV Healthcare Ltd, Brentford, Middlesex, United Kingdom

  ⨯